LY3471851

· Nektar Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3471851, covering 2023-09-05 to 2024-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) [Phase 2]